Results 91 to 100 of about 169,753,816 (340)

Quantum random number generation [PDF]

open access: yesnpj Quantum Information, 2015
Quantum physics can be exploited to generate true random numbers, which have important roles in many applications, especially in cryptography. Genuine randomness from the measurement of a quantum system reveals the inherent nature of quantumness ...
Xiong-Feng Ma   +4 more
semanticscholar   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk   +10 more
wiley   +1 more source

Number of tweets classified into each category.

open access: yes, 2022
Number of tweets classified into each category.
Beidi Dong (12153820)   +1 more
core   +1 more source

Choosing the Number of Categories in Agree–Disagree Scales [PDF]

open access: yesSociological Methods & Research, 2013
Although agree–disagree (AD) rating scales suffer from acquiescence response bias, entail enhanced cognitive burden, and yield data of lower quality, these scales remain popular with researchers due to practical considerations (e.g., ease of item preparation, speed of administration, and reduced administration costs).
Revilla, Melanie   +2 more
openaire   +2 more sources

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

New Interpretations of Cohen’s Kappa

open access: yesJournal of Mathematics, 2014
Cohen’s kappa is a widely used association coefficient for summarizing interrater agreement on a nominal scale. Kappa reduces the ratings of the two observers to a single number.
Matthijs J. Warrens
doaj   +1 more source

UPAYA MENINGKATKAN HASIL BELAJAR IPS MELALUI PENGGUNAAN MEDIA PETA PADA SISWA KELAS V SDN 005 BUKIT TIMAH DUMAI

open access: yesPrimary: Jurnal Pendidikan Guru Sekolah Dasar, 2017
This study aims to describe learning outcomes through the use of map media. This study is a classroom action research, the subject of research is the students of grade V SD 005 Bukit Timah Dumai with the number of 35 students.
Masnur Masnur
doaj   +1 more source

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann   +8 more
wiley   +1 more source

On the Turkish transnumeral as an aspect effectuation device

open access: yesEast European Journal of Psycholinguistics
This paper deals with the phenomenon of the Turkish transnumeral and its interplay with aspect. The transnumeral is a nominal/noun-phrase form interpreted as either singular or plural – i.e., numerically ambivalent and thus different from the standard ...
Sema Kutsarova
doaj   +1 more source

Number of indicators by category.

open access: yes, 2015
Number of indicators by category.
Claire O’Neill (716578)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy